Kizzmekia Corbett (Immunologist) Wiki, Biography, Age, Husband, Family, Net Worth

Kizzmekia Corbett Wiki,Biography, Net Worth

Kizzmekia Corbett is an American viral immunologist. She is the Shutzer Assistant Professor at the Harvard Radcliffe Institute and assistant professor of immunology and infectious diseases at Harvard T.H. Chan School of Public Health. She joined Harvard following six years at the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID NIH) based in Bethesda, Maryland. She earned a PhD in microbiology and immunology from the University of North Carolina at Chapel Hill (UNC-Chapel Hill) in 2014. Appointed to the VRC in 2014, Corbett was the scientific lead of the VRC’s Coronavirus Team, with research efforts aimed at propelling novel coronavirus vaccines, including a COVID-19 vaccine. In February 2021, Corbett was highlighted in the Time’s “Time100 Next” list under the category of Innovators, with a profile written by Anthony Fauci.

Explore Kizzmekia Corbett Wiki Age, Height, Biography as Wikipedia, Husband, Family relation. There is no question Kizzmekia Corbett is the most famous & most loved celebrity of all the time. You can find out how much net worth Kizzmekia has this year and how she spent her expenses. Also find out how she got rich at the age of 35. She has a pure loving kind heart personality. Scroll Down and find everything about her.

Kizzmekia Corbett Wiki, Biography

Date of Birth January 26, 1986
Birth Day January 26
Birth Years 1986
Age 35 years old
Birth Place Hurdle Mills, North Carolina, U.S.
Birth City North Carolina
Birth Country United States
Nationality American
Famous As immunologist
Also Known for immunologist
Zodiac Sign Scorpio
Occupation immunologist

Famously known by the Family name Kizzmekia, is a great immunologist. She was born on January 26, 1986, in Hurdle Mills, North Carolina, U.S.

. North Carolina is a beautiful and populous city located in Hurdle Mills, North Carolina, U.S.

United States.

Kizzmekia Corbett Early Life Story, Family Background and Education

Corbett was born in Hurdle Mills, North Carolina 1986, to Rhonda Brooks. She grew up in Hillsborough, North Carolina, where she had a large family of step-siblings and foster siblings.

Corbett went to Oak Lane Elementary School in Roxboro NC and A.L. Stanback Middle School. Her fourth grade teacher, Myrtis Bradsher, recalls recognizing Corbett’s talent at an early age and encouraging Kizzy’s mother to place her in advanced classes. “I always thought she is going to do something one day. She dotted i’s and crossed t’s. The best in my 30 years of teaching,” Bradsher said in a 2020 interview with The Washington Post.

In 2004, Corbett graduated from Orange High School in Hillsborough, North Carolina. In 2008, Corbett received a B.S. in biological sciences and sociology from the University of Maryland, Baltimore County (UMBC), as a student in the Meyerhoff Scholars Program. Corbett is among a cohort of recent UMBC graduates (also including Kaitlyn Sadtler) who have risen to prominence in biomedicine during the COVID-19 pandemic. In 2014, Corbett received a PhD in microbiology and immunology from the University of North Carolina at Chapel Hill. For her doctoral work, Corbett worked in Sri Lanka to study the role of human antibodies in dengue virus pathogenesis.

Read Also: Lorenzo Kamel Wiki, Biography, Age, Net Worth, Family, Instagram, Twitter, Social Profiles & More Facts

Kizzmekia Net Worth

Kizzmekia has a net worth of $5.00 million (Estimated) which she earned from her occupation as immunologist. Popularly known as the immunologist of United States. She is seen as one of the most successful immunologist of all times. Kizzmekia Net Worth & Basic source of earning is being a successful American immunologist.

Kizzmekia entered the career as immunologist In her early life after completing her formal education..

Net Worth

Estimated Net Worth in 2022 $1 Million to $5 Million Approx
Previous Year’s Net Worth (2021) Being Updated
Salary in 2021 Not Available
Annual Salary Being Updated
Cars Info Not Available
Income Source immunologist

Kizzmekia Corbett’s official Twitter account

The immunologist with a large number of Twitter followers, with whom she shares her life experiences. Kizzmekia is gaining More popularity of her Profession on Twitter these days. You can read today’s latest tweets and post from Kizzmekia Corbett’s official Twitter account below, where you can know what she is saying in her previous tweet. Read top and most recent tweets from his Twitter account here…

https://twitter.com/KizzyPhD

Social Network

Born on January 26, 1986, the immunologist Kizzmekia Corbett is arguably the world’s most influential social media star. Kizzmekia is an ideal celebrity influencer. With her large number of social media fans, she often posts many personal photos and videos to interact with her huge fan base on social media platforms. Personal touch and engage with her followers. You can scroll down for information about her Social media profiles.

Social Media Profiles and Accounts

Twitter Kizzmekia Corbett Official Twitter
Instagram Not Available
Facebook Not Available
Wikipedia Kizzmekia Corbett Wikipedia
YouTube Not Available
Spotify Not Available
Website Not Available
Itunes Not Available
Pandora Not Available
Googleplay Not Available
Deezer Not Available
Quora Not Available
Soundcloud Not Available

Life Story & Timeline

2020

To manufacture and test the COVID-19 vaccine Corbett’s team partnered with Moderna, a biotechnology company, to rapidly enter animal studies. Subsequently, the vaccine entered Phase 1 clinical trial only 66 days after the virus sequence was released. The trial, to be completed in at least 45 people, is a dose escalation study in the form of two injections separated by 28 days. Corbett’s work afforded her the opportunity to be a part of the National Institutes of Health team that welcomed Donald Trump to the Dale and Betty Bumpers Vaccine Research Center in March 2020.

2019

Corbett went to Oak Lane Elementary School and A.L. Stanback Middle School. Her fourth grade teacher, Myrtis Bradsher, recalls recognizing Corbett’s talent at an early age and encouraging Kizzy’s mother to place her in advanced classes. “I always thought she is going to do something one day. She dotted i’s and crossed t’s. The best in my 30 years of teaching,” Bradsher said in a 2020 interview with The Washington Post.

While in high school, Corbett realized that she wanted to pursue a scientific career, and as part of a program called ProjectSEED, spent her summer holiday working in research laboratories, one of which was at UNC’s Kenan Labs with organic chemist James Morkin. In 2005, she was a summer intern at SUNY StonyBrook in Gloria Viboud’s lab where she studied Yersinia pseudotuberculosis pathogenesis. From 2006 to 2007, she worked as a lab tech in Susan Dorsey’s lab at the University of Maryland School of Nursing.

At the onset of the COVID-19 pandemic, Corbett started working on a vaccine to protect people from coronavirus disease. Recognizing that the virus was similar to severe acute respiratory syndrome coronavirus, Corbett’s team utilized previous knowledge of optimal coronavirus S proteins to tackle the novel coronavirus. S proteins form a “crown” on the surface of coronaviruses and are crucial for engagement of host cell receptors and the initiation of membrane fusion in coronavirus disease. This makes them a particularly vulnerable target for coronavirus prophylactics and therapeutics. Based on her previous research, Corbett’s team, in collaboration with investigators at UT Austin, transplanted stabilizing mutations from SARS-CoV S protein into SARS-CoV-2 spike protein. She was part of the NIH team who helped solve the cryogenic electron microscopy (CryoEM) structure of the SARS-CoV-2 spike protein. Her prior research suggested that messenger RNA (mRNA) encoding S protein could be used to excite the immune response to produce protective antibodies against coronavirus disease 2019.

2014

In October 2014, Corbett became a research fellow, working as a viral immunologist, at the NIH. Her research aims to uncover mechanisms of viral pathogenesis and host immunity. She specifically focuses on development of novel vaccines for coronaviridae. Her early research considered the development of Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) vaccine antigens. During this time, she identified a simple way to make spike proteins that are stabilized in a conformation that renders them more immunogenic and manufacturable, in collaboration with researchers at Scripps Research Institute and Dartmouth College.

2009

From 2009 to 2014, Corbett studied human antibody responses to dengue virus in Sri Lankan children under the supervision of Aravinda de Silva at University of North Carolina at Chapel Hill. She studied how people produce antibodies in response to dengue fever, and how the genetics of dengue fever impact the severity of a disease. From April to May 2014, as part of her research for her dissertation, Corbett worked as a visiting scholar at Genetech Research Institute in Colombo, Sri Lanka.

2006

After earning her bachelor’s degree, from 2006 to 2009, Corbett was a biological sciences trainer at the National Institutes of Health (NIH), where she worked alongside Dr. Barney Graham. At the NIH, Corbett worked on the pathogenesis of respiratory syncytial virus pathogenesis as well as on a project focused on innovative vaccine platform advancement.

2004

In 2004, Corbett graduated from Orange High School in Hillsborough, North Carolina. In 2008, Corbett received a B.S. in biological sciences and sociology from the University of Maryland, Baltimore County (UMBC), as a student in the Meyerhoff Scholars Program. In 2014, Corbett received a PhD in microbiology and immunology from the University of North Carolina at Chapel Hill.

1986

Kizzmekia “Kizzy” Shanta Corbett (born January 26, 1986) is an American viral immunologist at the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID NIH) based in Bethesda, Maryland. Appointed to the VRC in 2014, she is currently the scientific lead of the VRC’s Coronavirus Team, with research efforts aimed at propelling novel coronavirus vaccines, including a COVID-19 vaccine.

Add Comment